188 related articles for article (PubMed ID: 7814829)
1. The importance of accidents in evaluating the cost of SSRIs: a review.
Hale AS
Int Clin Psychopharmacol; 1994 Sep; 9(3):195-201. PubMed ID: 7814829
[TBL] [Abstract][Full Text] [Related]
2. Are SSRIs a cost-effective alternative to tricyclics?
Hotopf M; Lewis G; Normand C
Br J Psychiatry; 1996 Apr; 168(4):404-9. PubMed ID: 8730935
[TBL] [Abstract][Full Text] [Related]
3. The behavioural toxicity of the selective serotonin reuptake inhibitors.
Hindmarch I
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():13-7. PubMed ID: 7622818
[TBL] [Abstract][Full Text] [Related]
4. SSRIs vs tricyclic antidepressants.
Griffin GH
J Fam Pract; 1996 Feb; 42(2):110. PubMed ID: 8606296
[No Abstract] [Full Text] [Related]
5. One foot on the bandwagon?
Pies R
J Clin Psychopharmacol; 1995 Oct; 15(5):303-5. PubMed ID: 8830060
[No Abstract] [Full Text] [Related]
6. Cost-benefit analysis of newer versus older antidepressants--pharmacoeconomic studies comparing SSRIs/SNRIs with tricyclic antidepressants.
Laux G
Pharmacopsychiatry; 2001 Jan; 34(1):1-5. PubMed ID: 11229615
[TBL] [Abstract][Full Text] [Related]
7. SSRIs versus tricyclics.
Rubinsztien JS; Michael A
Br J Psychiatry; 1996 Jul; 169(1):113-4. PubMed ID: 8818380
[No Abstract] [Full Text] [Related]
8. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.
Peveler R; Kendrick T; Buxton M; Longworth L; Baldwin D; Moore M; Chatwin J; Goddard J; Thornett A; Smith H; Campbell M; Thompson C
Health Technol Assess; 2005 May; 9(16):1-134, iii. PubMed ID: 15876362
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trial.
Kendrick T; Peveler R; Longworth L; Baldwin D; Moore M; Chatwin J; Thornett A; Goddard J; Campbell M; Smith H; Buxton M; Thompson C
Br J Psychiatry; 2006 Apr; 188():337-45. PubMed ID: 16582060
[TBL] [Abstract][Full Text] [Related]
10. Influences on cost effectiveness.
Patel V
Br J Psychiatry; 1996 Sep; 169(3):381. PubMed ID: 8879730
[No Abstract] [Full Text] [Related]
11. An analysis of the diffusion of new antidepressants: variety, quality, and marketing efforts.
Berndt ER; Bhattacharjya A; Mishol DN; Arcelus A; Lasky T
J Ment Health Policy Econ; 2002 Mar; 5(1):3-19. PubMed ID: 12529566
[TBL] [Abstract][Full Text] [Related]
12. Economic outcomes associated with tricyclic antidepressant and selective serotonin reuptake inhibitor treatments for depression.
Crown WH
Acta Psychiatr Scand Suppl; 2000; 403():62-6. PubMed ID: 11019937
[TBL] [Abstract][Full Text] [Related]
13. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.
Anderson IM; Tomenson BM
BMJ; 1995 Jun; 310(6992):1433-8. PubMed ID: 7613276
[TBL] [Abstract][Full Text] [Related]
14. Effect of antidepressant choice on the incidence and economic intensity of hospitalization among depressed individuals.
Croghan TW; Kniesner TJ; Melfi CA; Robinson RL
Adm Policy Ment Health; 2000 Mar; 27(4):183-95. PubMed ID: 10911668
[TBL] [Abstract][Full Text] [Related]
15. TCAs or SSRIs as initial therapy for depression?
Tyra JM; Greenawald MH
J Fam Pract; 1999 Nov; 48(11):845-6. PubMed ID: 10907616
[No Abstract] [Full Text] [Related]
16. Pharmacological treatment of depression with and without headache disorders: an appraisal of cost effectiveness and cost utility of antidepressants.
Pan YJ; Kuo KH; Wang SJ
J Affect Disord; 2015 Jan; 170():255-65. PubMed ID: 25261631
[TBL] [Abstract][Full Text] [Related]
17. Sertraline. A pharmacoeconomic evaluation of its use in depression.
Davis R; Wilde MI
Pharmacoeconomics; 1996 Oct; 10(4):409-31. PubMed ID: 10184609
[TBL] [Abstract][Full Text] [Related]
18. Treatment of severe depression with the selective serotonin reuptake inhibitors.
Schatzberg AF
Depress Anxiety; 1996-1997; 4(4):182-9. PubMed ID: 9166650
[TBL] [Abstract][Full Text] [Related]
19. Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity.
Hotopf M; Hardy R; Lewis G
Br J Psychiatry; 1997 Feb; 170():120-7. PubMed ID: 9093499
[TBL] [Abstract][Full Text] [Related]
20. Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses.
Taylor D
Br J Psychiatry; 1995 Nov; 167(5):575-80. PubMed ID: 8564311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
